nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—peripheral nervous system neoplasm	0.435	0.719	CbGaD
Perindopril—ABCB1—peripheral nervous system neoplasm	0.171	0.282	CbGaD
Perindopril—BCHE—Cisplatin—peripheral nervous system neoplasm	0.056	0.273	CbGbCtD
Perindopril—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0357	0.174	CbGbCtD
Perindopril—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0357	0.174	CbGbCtD
Perindopril—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0247	0.121	CbGbCtD
Perindopril—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0152	0.0743	CbGbCtD
Perindopril—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0142	0.0693	CbGbCtD
Perindopril—ABCB1—Etoposide—peripheral nervous system neoplasm	0.014	0.0681	CbGbCtD
Perindopril—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00952	0.0464	CbGbCtD
Perindopril—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.00355	0.34	CbGeAlD
Perindopril—ACE—forelimb—peripheral nervous system neoplasm	0.00178	0.171	CbGeAlD
Perindopril—ACE—arm—peripheral nervous system neoplasm	0.00153	0.147	CbGeAlD
Perindopril—Ramipril—BCHE—peripheral nervous system neoplasm	0.00113	0.588	CrCbGaD
Perindopril—ACE—nerve—peripheral nervous system neoplasm	0.000975	0.0936	CbGeAlD
Perindopril—ACE—ganglion—peripheral nervous system neoplasm	0.000963	0.0924	CbGeAlD
Perindopril—Cilazapril—ABCB1—peripheral nervous system neoplasm	0.000459	0.238	CrCbGaD
Perindopril—SLC15A2—parotid gland—peripheral nervous system neoplasm	0.000389	0.0373	CbGeAlD
Perindopril—BCHE—trigeminal ganglion—peripheral nervous system neoplasm	0.00035	0.0335	CbGeAlD
Perindopril—Enalapril—ABCB1—peripheral nervous system neoplasm	0.000337	0.175	CrCbGaD
Perindopril—BCHE—brainstem—peripheral nervous system neoplasm	0.000309	0.0297	CbGeAlD
Perindopril—SLC15A2—cerebellum—peripheral nervous system neoplasm	0.00018	0.0173	CbGeAlD
Perindopril—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000167	0.016	CbGeAlD
Perindopril—BCHE—cerebellum—peripheral nervous system neoplasm	0.000153	0.0146	CbGeAlD
Perindopril—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.96e-05	0.00045	CcSEcCtD
Perindopril—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.95e-05	0.000449	CcSEcCtD
Perindopril—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000447	CcSEcCtD
Perindopril—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.89e-05	0.000446	CcSEcCtD
Perindopril—Somnolence—Etoposide—peripheral nervous system neoplasm	7.87e-05	0.000444	CcSEcCtD
Perindopril—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000444	CcSEcCtD
Perindopril—Asthenia—Vincristine—peripheral nervous system neoplasm	7.84e-05	0.000443	CcSEcCtD
Perindopril—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000442	CcSEcCtD
Perindopril—Drowsiness—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000439	CcSEcCtD
Perindopril—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.77e-05	0.000439	CcSEcCtD
Perindopril—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000438	CcSEcCtD
Perindopril—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.76e-05	0.000438	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000436	CcSEcCtD
Perindopril—Rash—Dactinomycin—peripheral nervous system neoplasm	7.71e-05	0.000435	CcSEcCtD
Perindopril—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.69e-05	0.000434	CcSEcCtD
Perindopril—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000433	CcSEcCtD
Perindopril—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000432	CcSEcCtD
Perindopril—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.64e-05	0.000432	CcSEcCtD
Perindopril—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.63e-05	0.000431	CcSEcCtD
Perindopril—Fatigue—Etoposide—peripheral nervous system neoplasm	7.63e-05	0.000431	CcSEcCtD
Perindopril—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000428	CcSEcCtD
Perindopril—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000428	CcSEcCtD
Perindopril—Pain—Etoposide—peripheral nervous system neoplasm	7.57e-05	0.000427	CcSEcCtD
Perindopril—Constipation—Etoposide—peripheral nervous system neoplasm	7.57e-05	0.000427	CcSEcCtD
Perindopril—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000427	CcSEcCtD
Perindopril—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000427	CcSEcCtD
Perindopril—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000426	CcSEcCtD
Perindopril—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000424	CcSEcCtD
Perindopril—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.5e-05	0.000423	CcSEcCtD
Perindopril—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.47e-05	0.000422	CcSEcCtD
Perindopril—Sweating—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000421	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000421	CcSEcCtD
Perindopril—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000419	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000416	CcSEcCtD
Perindopril—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000415	CcSEcCtD
Perindopril—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000414	CcSEcCtD
Perindopril—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000412	CcSEcCtD
Perindopril—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.29e-05	0.000412	CcSEcCtD
Perindopril—ABCB1—cerebellum—peripheral nervous system neoplasm	7.27e-05	0.00697	CbGeAlD
Perindopril—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.26e-05	0.00041	CcSEcCtD
Perindopril—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.00041	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000409	CcSEcCtD
Perindopril—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.24e-05	0.000409	CcSEcCtD
Perindopril—Dizziness—Vincristine—peripheral nervous system neoplasm	7.22e-05	0.000408	CcSEcCtD
Perindopril—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.21e-05	0.000407	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000406	CcSEcCtD
Perindopril—Rash—Alitretinoin—peripheral nervous system neoplasm	7.15e-05	0.000404	CcSEcCtD
Perindopril—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.14e-05	0.000403	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000403	CcSEcCtD
Perindopril—Bradycardia—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000401	CcSEcCtD
Perindopril—Headache—Alitretinoin—peripheral nervous system neoplasm	7.1e-05	0.000401	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.0004	CcSEcCtD
Perindopril—Urticaria—Etoposide—peripheral nervous system neoplasm	7.03e-05	0.000397	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000396	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000396	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000396	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000395	CcSEcCtD
Perindopril—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000395	CcSEcCtD
Perindopril—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000395	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000395	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000395	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000394	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000394	CcSEcCtD
Perindopril—Vomiting—Vincristine—peripheral nervous system neoplasm	6.94e-05	0.000392	CcSEcCtD
Perindopril—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.93e-05	0.000391	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000391	CcSEcCtD
Perindopril—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.00039	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000389	CcSEcCtD
Perindopril—Rash—Vincristine—peripheral nervous system neoplasm	6.89e-05	0.000389	CcSEcCtD
Perindopril—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.88e-05	0.000389	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000388	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000388	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000387	CcSEcCtD
Perindopril—Headache—Vincristine—peripheral nervous system neoplasm	6.84e-05	0.000387	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000384	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000383	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000381	CcSEcCtD
Perindopril—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.73e-05	0.00038	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.00038	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.000379	CcSEcCtD
Perindopril—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.61e-05	0.000373	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000373	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000371	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000369	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.51e-05	0.000368	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000367	CcSEcCtD
Perindopril—Nausea—Vincristine—peripheral nervous system neoplasm	6.49e-05	0.000366	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000366	CcSEcCtD
Perindopril—Flushing—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000366	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000366	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000365	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000365	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000362	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.00036	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000359	CcSEcCtD
Perindopril—Asthenia—Etoposide—peripheral nervous system neoplasm	6.35e-05	0.000359	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000358	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000358	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.29e-05	0.000355	CcSEcCtD
Perindopril—Chills—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000354	CcSEcCtD
Perindopril—Pruritus—Etoposide—peripheral nervous system neoplasm	6.26e-05	0.000354	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000352	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000352	CcSEcCtD
Perindopril—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000348	CcSEcCtD
Perindopril—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.14e-05	0.000347	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000345	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000345	CcSEcCtD
Perindopril—Rash—Cisplatin—peripheral nervous system neoplasm	6.09e-05	0.000344	CcSEcCtD
Perindopril—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.08e-05	0.000344	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000343	CcSEcCtD
Perindopril—Erythema—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000343	CcSEcCtD
Perindopril—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.05e-05	0.000342	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000341	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.00034	CcSEcCtD
Perindopril—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000339	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000339	CcSEcCtD
Perindopril—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.99e-05	0.000338	CcSEcCtD
Perindopril—Tension—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000337	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000336	CcSEcCtD
Perindopril—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000333	CcSEcCtD
Perindopril—Back pain—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000332	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000331	CcSEcCtD
Perindopril—Dizziness—Etoposide—peripheral nervous system neoplasm	5.85e-05	0.000331	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.00033	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.82e-05	0.000329	CcSEcCtD
Perindopril—Chills—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000327	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000326	CcSEcCtD
Perindopril—Nausea—Cisplatin—peripheral nervous system neoplasm	5.74e-05	0.000324	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000322	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.00032	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000319	CcSEcCtD
Perindopril—Vomiting—Etoposide—peripheral nervous system neoplasm	5.63e-05	0.000318	CcSEcCtD
Perindopril—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000318	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000318	CcSEcCtD
Perindopril—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000317	CcSEcCtD
Perindopril—Agitation—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000315	CcSEcCtD
Perindopril—Rash—Etoposide—peripheral nervous system neoplasm	5.58e-05	0.000315	CcSEcCtD
Perindopril—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.57e-05	0.000315	CcSEcCtD
Perindopril—Headache—Etoposide—peripheral nervous system neoplasm	5.54e-05	0.000313	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.000313	CcSEcCtD
Perindopril—Tension—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000312	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000311	CcSEcCtD
Perindopril—Malaise—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.00031	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000309	CcSEcCtD
Perindopril—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000308	CcSEcCtD
Perindopril—Syncope—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000308	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000307	CcSEcCtD
Perindopril—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000307	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000305	CcSEcCtD
Perindopril—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000303	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000302	CcSEcCtD
Perindopril—Cough—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.0003	CcSEcCtD
Perindopril—Nausea—Etoposide—peripheral nervous system neoplasm	5.26e-05	0.000297	CcSEcCtD
Perindopril—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000296	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000295	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000294	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000292	CcSEcCtD
Perindopril—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000292	CcSEcCtD
Perindopril—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000292	CcSEcCtD
Perindopril—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000292	CcSEcCtD
Perindopril—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000291	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.14e-05	0.00029	CcSEcCtD
Perindopril—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000289	CcSEcCtD
Perindopril—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000286	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000286	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000285	CcSEcCtD
Perindopril—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000285	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000284	CcSEcCtD
Perindopril—Confusional state—Epirubicin—peripheral nervous system neoplasm	5e-05	0.000282	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000281	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.00028	CcSEcCtD
Perindopril—Oedema—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.00028	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000279	CcSEcCtD
Perindopril—Cough—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000277	CcSEcCtD
Perindopril—Shock—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000276	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000275	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000274	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000274	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000273	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000272	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000271	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.00027	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.00027	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.00027	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000269	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000269	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000267	CcSEcCtD
Perindopril—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000267	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000264	CcSEcCtD
Perindopril—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000262	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000261	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000259	CcSEcCtD
Perindopril—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000259	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000255	CcSEcCtD
Perindopril—Shock—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000255	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000254	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.000254	CcSEcCtD
Perindopril—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000253	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000253	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000252	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000252	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000251	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.00025	CcSEcCtD
Perindopril—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000249	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000247	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000247	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000244	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000242	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000242	CcSEcCtD
Perindopril—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000242	CcSEcCtD
Perindopril—Pain—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.00024	CcSEcCtD
Perindopril—Constipation—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.00024	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000236	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000234	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000233	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000231	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000231	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.00023	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000229	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000228	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000225	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000224	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000223	CcSEcCtD
Perindopril—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000223	CcSEcCtD
Perindopril—Pain—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000222	CcSEcCtD
Perindopril—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000222	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000221	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000221	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000214	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000212	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000206	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000205	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000205	CcSEcCtD
Perindopril—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000201	CcSEcCtD
Perindopril—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.51e-05	0.000198	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000192	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000186	CcSEcCtD
Perindopril—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.28e-05	0.000185	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000183	CcSEcCtD
Perindopril—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000178	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000177	CcSEcCtD
Perindopril—Rash—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000177	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000176	CcSEcCtD
Perindopril—Headache—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000176	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000171	CcSEcCtD
Perindopril—Nausea—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000166	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000165	CcSEcCtD
Perindopril—Rash—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000163	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000163	CcSEcCtD
Perindopril—Headache—Doxorubicin—peripheral nervous system neoplasm	2.87e-05	0.000162	CcSEcCtD
Perindopril—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000154	CcSEcCtD
